{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:58:15Z","timestamp":1788400695887,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.lfs.2022.120446","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T19:33:40Z","timestamp":1646163220000},"page":"120446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ceramide kinase knockout ameliorates multiple sclerosis-like behaviors and demyelination in cuprizone-treated mice"],"prefix":"10.1016","volume":"296","author":[{"given":"Ai","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Anada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Yasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120446_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2017.12.022","article-title":"Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and near-degeneration","volume":"385","author":"Podbielska","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2022.120446_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2020.100039","article-title":"Immune-mediated genesis of multiple sclerosis","volume":"3","author":"Cavallo","year":"2020","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.lfs.2022.120446_bb0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2022.120446_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2022.120446_bb0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fneur.2020.00437","article-title":"Exploring sphingolipid implications in neurodegeneration","volume":"11","author":"Alessenko","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2022.120446_bb0030","doi-asserted-by":"crossref","first-page":"41888","DOI":"10.1074\/jbc.M112.413500","article-title":"Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes","volume":"287","author":"Ginkel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120446_bb0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3681","article-title":"Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation","volume":"20","author":"Mayo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.120446_bb0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/icb.2015.47","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation\/migration of neutrophils","volume":"93","author":"Eberle","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2022.120446_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178622","article-title":"Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination","volume":"12","author":"Chami","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.120446_bb0050","doi-asserted-by":"crossref","first-page":"23294","DOI":"10.1074\/jbc.M201535200","article-title":"Ceramide kinase, a novel lipid kinase: molecular cloning and functional characterization","volume":"277","author":"Sugiura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120446_bb0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bcp.2005.12.027","article-title":"Ceramide-1-phosphate activates cytosolic phospholipase A2\u03b1 directly and by PKC pathway","volume":"71","author":"Nakamura","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120446_bb0060","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1002\/jcb.27818","article-title":"Translocation and activation of sphingosine kinase 1 by ceramide-1-phosphate","volume":"120","author":"Nishino","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2022.120446_bb0065","article-title":"Novel signaling aspects of ceramide 1-phosphate","volume":"1865","author":"Presa","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2022.120446_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbrc.2007.09.010","article-title":"The generation and behavioral analysis of ceramide kinase-null mice, indicating a function in cerebellar Purkinje cells","volume":"363","author":"Mitsutake","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2022.120446_bb0075","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.4049\/jimmunol.180.5.3457","article-title":"Neutropenia with impaired immune response to Streptococcus pneumonia in ceramide kinase-deficient mice","volume":"180","author":"Graf","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2022.120446_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1248\/bpb.b18-00051","article-title":"Knockout of ceramide kinase aggravates pathological and lethal responses in mice with experimental colitis","volume":"41","author":"Suzuki","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2022.120446_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.toxlet.2007.01.010","article-title":"Behavioral deficits in the cuprizone-induced murine model of demyelination\/remyelination","volume":"169","author":"Franco-Pons","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2022.120446_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1750-3639.2008.00230.x","article-title":"SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination","volume":"19","author":"Taylor","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.lfs.2022.120446_bb0095","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.lfs.2022.120446_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neubiorev.2014.10.004","article-title":"Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis","volume":"47","author":"Praet","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2022.120446_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","article-title":"Behavioral phenotypes in the cuprizone model of central nervous system demyelination","volume":"107","author":"Sen","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.lfs.2022.120446_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbr.2017.05.045","article-title":"Increased central dopaminergic activity might be involved in the behavioral abnormality of cuprizone exposure mice","volume":"331","author":"Chang","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2022.120446_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","article-title":"An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization","volume":"19","author":"Weaver","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.120446_bb0120","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1096\/fj.201700524R","article-title":"Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37","volume":"31","author":"Giacoppo","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.120446_bb0125","article-title":"Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice","volume":"86","author":"Bittner","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.lfs.2022.120446_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainresbull.2020.10.015","article-title":"[Met5]-enkephalin preserves diffusion metrics in EAE mice","volume":"165","author":"Patel","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2022.120446_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12035-018-1040-x","article-title":"Modulatory effects of fingolimod (FTY720) on the expression of sphingolipid metabolism-related genes in an animal model of Alzheimer's disease","volume":"56","author":"J\u0119\u015bko","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2022.120446_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2012.07.006","article-title":"Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis","volume":"1472","author":"Campbell","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2022.120446_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12031-019-01312-0","article-title":"Animal weight is an important variable for reliable cuprizone-induced demyelination","volume":"68","author":"Leopold","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/cells9040843","article-title":"The cuprizone model: dos and do nots","volume":"9","author":"Zhan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2022.120446_bb0160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1037\/a0014477","article-title":"Behavioral and neurobiological changes in C57BL\/6 mice exposed to cuprizone","volume":"123","author":"Xu","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12031-010-9354-9","article-title":"Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration","volume":"42","author":"Werner","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.npep.2017.10.002","article-title":"Humanin affects object recognition and gliosis in short-term cuprizone-treated mice","volume":"66","author":"Murakami","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.lfs.2022.120446_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12031-012-9773-x","article-title":"Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cupriszone-induced demyelination","volume":"48","author":"Buschmann","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nn.2491","article-title":"CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis","volume":"13","author":"Liu","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2022.120446_bb0185","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.3390\/ijms21124558","article-title":"Neutrophils: underestimated players in the pathogenesis of multiple sclerosis (MS)","volume":"21","author":"De Bondt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120446_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nbd.2013.07.003","article-title":"Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis","volume":"59","author":"Tezuka","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.lfs.2022.120446_bb0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.plefa.2013.08.008","article-title":"Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2","volume":"89","author":"Palumbo","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.lfs.2022.120446_bb0200","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1194\/jlr.M035683","article-title":"Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase","volume":"54","author":"Mietla","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2022.120446_bb0205","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.febslet.2012.03.032","article-title":"Ceramide kinase deficiency improves diet-induced obesity and insulin resistance","volume":"586","author":"Mitsutake","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2022.120446_bb0210","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1096\/fj.10-173203","article-title":"Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model","volume":"25","author":"Kim","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.120446_bb0215","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bph.12938","article-title":"The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination","volume":"172","author":"Slowik","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120446_bb0220","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1194\/jlr.M048207","article-title":"Ceramide kinase is tequired for a normal eicosanoid response and the subsequent orderly migration of fibroblasts","volume":"55","author":"Wijesinghe","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2022.120446_bb0225","doi-asserted-by":"crossref","first-page":"42808","DOI":"10.1074\/jbc.M111.310169","article-title":"Ceramide kinase regulates the production of tumor necrosis factor \u03b1 (TNF\u03b1) via inhibition of TNF\u03b1-converting enzyme","volume":"286","author":"Lamour","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120446_bb0230","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.1402681","article-title":"C1P attenuates lipopolysaccharide-induced acute lung injury by preventing NF-\u03baB activation in neutrophils","volume":"196","author":"Baudi\u03b2","year":"2016","journal-title":"J. Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:57:11Z","timestamp":1758401831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":46,"alternative-id":["S0024320522001461"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120446","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceramide kinase knockout ameliorates multiple sclerosis-like behaviors and demyelination in cuprizone-treated mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120446"}}